Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC is a research paper published in Journal of Thoracic Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30-CA086485
National Institutes of Health
Grant: S21MD000104
National Institutes of Health
Grant: U01CA224276-01
National Institutes of Health
Grant: U54CA217450-01
National Institutes of Health
Grant: UG1CA233259
National Center for Advancing Translational Sciences
Grant: UL1TR000445
National Cancer Institute
Grant: U2C CA233280
Conquer Cancer Foundation
Grant: 1U01 CA224012
Conquer Cancer Foundation
Grant: R01 CA223150
Conquer Cancer Foundation
Grant: R01 CA226909
Conquer Cancer Foundation
Grant: R21 HD099367
Conquer Cancer Foundation
Grant: R50CA243783
Conquer Cancer Foundation
Grant: U54CA217450
NCI NIH HHS
Grant: K12 CA090625
NIH HHS
Grant: S10 OD023475
NCI NIH HHS
Grant: U01 CA224276
NCI NIH HHS
Grant: P30 CA068485
NIH HHS
Grant: S10 OD016355
NCI NIH HHS
Grant: U01 CA224012
Knight Cancer Institute, Oregon Health and Science University
Vanderbilt-Ingram Cancer Center
Oregon Health and Science University
MeSH Terms
Keywords